kamala harris – Michmutters
Categories
US

Biden signs China competition bill to boost US chipmakers

[ The stream is slated to start at 10 a.m. ET. Please refresh if you do not see a player above at that time.]

President Joe Biden on Tuesday signed a bipartisan bill that aims to strengthen US competitiveness with China by investing billions of dollars in domestic semiconductor manufacturing and science research.

“Today is a day for builders. Today America is delivering,” Biden said at the signing ceremony outside the White House. He was joined by a crowd of hundreds, including tech executives, union presidents and political leaders from both parties.

The bill, dubbed the Chips and Science Act, includes more than $52 billion for US companies producing computer chips, as well as billions more in tax credits to encourage investment in semiconductor manufacturing. It also provides tens of billions of dollars to fund scientific research and development, and to spur the innovation and development of other US tech.

The Biden administration also contended that the legislation will “unlock hundreds of billions more” in private spending in the industry. The White House said Tuesday that multiple companies, “spurred” by the chips bill, have announced more than $44 billion in new semiconductor manufacturing investments.

US President Joe Biden (C) signs HR 4346, the CHIPS and Science Act of 2022, on the South Lawn of the White House in Washington, DC, on August 9, 2022.

Mandel Ngan | Afp | Getty Images

Of that sum, $40 billion is coming from Micron’s investment in memory chip manufacturing. The White House said the company’s initiative will yield 8,000 new jobs and increase the US market share of memory chip production to 10% from 2%.

A newly announced partnership between Qualcomm and GlobalFoundries, meanwhile, includes $4.2 billion in chip production as part of an expansion of GlobalFoundries’ upstate New York facility, the White House said.

Advocates say the funding is needed to sharpen America’s technological edge and reinvigorate its lagging chip industry. The US produces only about 10% of the world’s supply of semiconductors, whereas East Asia accounts for 75% of global production — including most of the top-tier chips, according to the White House.

Semiconductors are critical pieces of an array of products including consumer electronics, automobiles, health care equipment and weapons systems. The Covid-19 pandemic sparked a chip shortage and strained supply chains, highlighting America’s dependence on foreign-made chips and revealing a potential national security threat, officials say.

The signing comes as Biden and congressional Democrats cap a flurry of activity before lawmakers leave Washington for the rest of the month and turn their attention to midterm election campaigns.

Senate Democrats on Sunday passed a sweeping bill to fund ambitious climate, energy and health policies by raising taxes on rich corporations and reforming prescription drug pricing. The bill, a major piece of Biden’s agenda that Democrats had worked on for well over a year, squeaked through with no Republican support in the chamber, which is evenly split by party. Vice President Kamala Harris cast the tie-breaking vote.

In late June, Biden also signed a bipartisan bill to strengthen gun regulations, including by enhancing requirements for background checks. The legislation sped through Congress in the wake of a deadly mass shooting at an elementary school in Uvalde, Texas, in which a single gunman killed 19 students and two teachers.

And last week, Biden revealed that a US strike in Afghanistan killed top al-Qaeda leader Ayman Al-Zawahiri, who was considered a mastermind behind the 9/11 terrorist attacks.

Biden is also expected to sign another bill this week that bolsters health benefits for veterans who were exposed to chemicals that billowed from toxic burn pits.

That bill passed with overwhelming bipartisan support after Republicans temporarily blocked it. The move stoked outrage from some veterans’ groups, as well as comedian Jon Stewart, who emerged as a leading advocate.

Biden’s already-middling approval ratings have sunk in recent months, as global inflation and supply chain issues take a toll on Americans’ wallets at the grocery store and the gas station. His unpopularity of him, paired with a tough political map and other political headwinds, has fueled concerns among Democrats that they could suffer a route in the November midterms that results in Republicans taking control of one or both chambers of Congress.

But the latest polls show Democrats’ chances of keeping the Senate have improved, and Biden on Monday predicted that the climate and tax bill’s passage will “immediately help” in the midterms.

.

Categories
US

Biden signs China competition bill to boost US chipmakers

[ The stream is slated to start at 10 a.m. ET. Please refresh if you do not see a player above at that time.]

President Joe Biden on Tuesday signed a bipartisan bill that aims to strengthen US competitiveness with China by investing billions of dollars in domestic semiconductor manufacturing and science research.

“Today is a day for builders. Today America is delivering,” Biden said at the signing ceremony outside the White House. He was joined by a crowd of hundreds, including tech executives, union presidents and political leaders from both parties.

The bill, dubbed the Chips and Science Act, includes more than $52 billion for US companies producing computer chips, as well as billions more in tax credits to encourage investment in semiconductor manufacturing. It also provides tens of billions of dollars to fund scientific research and development, and to spur the innovation and development of other US tech.

The Biden administration also contended that the legislation will “unlock hundreds of billions more” in private spending in the industry. The White House said Tuesday that multiple companies, “spurred” by the chips bill, have announced more than $44 billion in new semiconductor manufacturing investments.

US President Joe Biden (C) signs HR 4346, the CHIPS and Science Act of 2022, on the South Lawn of the White House in Washington, DC, on August 9, 2022.

Mandel Ngan | Afp | Getty Images

Of that sum, $40 billion is coming from Micron’s investment in memory chip manufacturing. The White House said the company’s initiative will yield 8,000 new jobs and increase the US market share of memory chip production to 10% from 2%.

A newly announced partnership between Qualcomm and GlobalFoundries, meanwhile, includes $4.2 billion in chip production as part of an expansion of GlobalFoundries’ upstate New York facility, the White House said.

Advocates say the funding is needed to sharpen America’s technological edge and reinvigorate its lagging chip industry. The US produces only about 10% of the world’s supply of semiconductors, whereas East Asia accounts for 75% of global production — including most of the top-tier chips, according to the White House.

Semiconductors are critical pieces of an array of products including consumer electronics, automobiles, health care equipment and weapons systems. The Covid-19 pandemic sparked a chip shortage and strained supply chains, highlighting America’s dependence on foreign-made chips and revealing a potential national security threat, officials say.

The signing comes as Biden and congressional Democrats cap a flurry of activity before lawmakers leave Washington for the rest of the month and turn their attention to midterm election campaigns.

Senate Democrats on Sunday passed a sweeping bill to fund ambitious climate, energy and health policies by raising taxes on rich corporations and reforming prescription drug pricing. The bill, a major piece of Biden’s agenda that Democrats had worked on for well over a year, squeaked through with no Republican support in the chamber, which is evenly split by party. Vice President Kamala Harris cast the tie-breaking vote.

In late June, Biden also signed a bipartisan bill to strengthen gun regulations, including by enhancing requirements for background checks. The legislation sped through Congress in the wake of a deadly mass shooting at an elementary school in Uvalde, Texas, in which a single gunman killed 19 students and two teachers.

And last week, Biden revealed that a US strike in Afghanistan killed top al-Qaeda leader Ayman Al-Zawahiri, who was considered a mastermind behind the 9/11 terrorist attacks.

Biden is also expected to sign another bill this week that bolsters health benefits for veterans who were exposed to chemicals that billowed from toxic burn pits.

That bill passed with overwhelming bipartisan support after Republicans temporarily blocked it. The move stoked outrage from some veterans’ groups, as well as comedian Jon Stewart, who emerged as a leading advocate.

Biden’s already-middling approval ratings have sunk in recent months, as global inflation and supply chain issues take a toll on Americans’ wallets at the grocery store and the gas station. His unpopularity of him, paired with a tough political map and other political headwinds, has fueled concerns among Democrats that they could suffer a route in the November midterms that results in Republicans taking control of one or both chambers of Congress.

But the latest polls show Democrats’ chances of keeping the Senate have improved, and Biden on Monday predicted that the climate and tax bill’s passage will “immediately help” in the midterms.

.

Categories
US

Senate passes Inflation Reduction Act, Democrats’ climate, health and tax bill, delivering win for Biden

Washington— The Senate on Sunday passed Democrats’ sweeping economy package designed to combat climate change, address health care costs and raise taxes on large corporations, marking a crucial achievement for President Biden and his party as they look to maintain their hold on Congress in the November midterm elections.

The plan, called the Inflation Reduction Act, cleared the upper chamber by a vote of 51 to 50 along party lines, with Vice President Kamala Harris providing the tie-breaking vote in the evenly divided Senate. Democrats used a fast-track legislative process known as reconciliation to pass the measure in the face of unanimous opposition from Republicans.

“It’s been a long, tough and winding road but at last, at last, we have arrived,” Senate Majority Leader Chuck Schumer said in remarks on the Senate floor as members prepared to vote for final passage. “Today, after more than a year of hard work, the Senate is making history. I am confident the Inflation Reduction Act will endure as one of the defining legislative feats of the 21st century.”

The vote came after a marathon session that lasted through the night and into Sunday afternoon, with Democrats breaking into applause as members cast their final votes. In a process known as a “vote-a-rama,” Republicans offered a slew of amendments that Democrats successfully swatted down over nearly 16 hours of debate.

GOP senators did manage to block a provision that would have capped the price of insulin at $35 a month for those covered under private health care plans. Democrats needed 60 votes to waive reconciliation rules and keep that part of the bill, but it failed 57 to 43, with seven Republicans joining Democrats in support of the measure.

House Democratic leaders announced last week the lower chamber will return from its month-long recess on Friday to take up the legislation, which is expected to pass.

Mr. Biden praised Senate Democrats for passing the plan and acknowledged it required “many compromises.” He urged the House to swiftly approve the bill.

“Today, Senate Democrats sided with American families over special interests, voting to lower the cost of prescription drugs, health insurance, and everyday energy costs and reduce the deficit, while making the wealthiest corporations finally pay their fair share,” the president said in to statement. “I ran for president promising to make government work for working families again, and that is what this bill does — period.”

The package is the culmination of months of negotiations over Mr. Biden’s domestic policy agenda, which at times appeared to be on life support but was revived late last month with the surprise announcement of an agreement between Schumer and Sen. Joe Manchin, a moderate Democrat from West Virginia.

WASHINGTON, DC - AUGUST 6: Senator Joe Manchin (D-WV) chats wit
Sen. Joe Manchin chats with his staffers on Capitol Hill in Washington on Aug. 6, 2022.

Shuran Huang for The Washington Post via Getty Images


While the legislation is much more narrow than the sprawling $3.5 trillion proposal put forth by Mr. Biden last year, the tailored package had the backing of Manchin and Sen. Kyrsten Sinema, a Democrat from Arizona whose support was crucial.

Still, Democrats praise the plan as their answer to addressing rising consumer prices and for its nearly $400 billion investment in fighting climate change, the largest ever. The package allows Medicare to negotiate prescription drug prices, a key Democratic priority that is expected to save hundreds of billions of dollars over the next 10 years. It also extends enhanced health insurance subsidies that were set to expire at the end of the year, and imposes a 15% minimum tax on most corporations that make more than $1 billion each year.

The corporate tax provision emerged as a point of contention as senators neared a final vote on Sunday. Seven Democratic senators — Sinema, Jon Ossoff, Raphael Warnock, Catherine Cortez Masto, Maggie Hassan, Mark Kelly and Jacky Rosen — joined Republicans in backing an amendment put forward by GOP Sen. John Thune of South Dakota exempts some firms with private equity backing from the 15% minimum corporate tax rate. That amendment passed 57 to 43.

To boost clean energy, the measure includes tax credits for buying electric vehicles and manufacturing solar panels and wind turbines. It also provides rebates for consumers who buy energy efficient appliances and provides $4 billion for drought relief.

Schumer lauded the bill as the “boldest climate package” in US history, and called it a “game-changer” and “turning point.”

“It’s been a long time coming,” he said.

One piece of Democrats’ drug-pricing plan — imposing penalties on drug manufacturers that raised prices beyond inflation on private insurers — was removed after it was reviewed by Senate parliamentarian Elizbeth MacDonough. Her approval of the rest of the package, however, cleared the way for the upper chamber to move forward with its consideration of the bill.

The Congressional Budget Office estimates the legislation will cut the deficit by $102 billion over the next 10 years. Republicans, though, argued the plan will have little impact on inflation and instead raise taxes while leading to job losses.

in an interview with “Face the Nation” on Sunday, Sen. Rick Scott, a Republican from Florida, claimed Democrats’ drug pricing plan will harm seniors, while the tax component will increase taxes on Americans.

“Why would you be increasing the cost of government? We’re increasing taxes,” he said.

.

Categories
US

Harris moves within six tie-breaking votes of nearly 200-year-old record

Vice President Harris cast her 25th tie breaking vote with the passage of the Inflation Reduction Act on Sunday, moving her within six votes of the almost two-century-old record held by former Vice President John Calhoun.

The Constitution stipulates the vice president also serves as president of the Senate and has the authority to break ties, which has occurred with some regularity over the past year and a half given the 50-50 makeup of the upper chamber.

Harris has already cast more tiebreakers than almost any other vice president, except for John Adams and Calhoun, who served from 1825 to 1832.

Calhoun has held the record of 31 tie-breaking votes since his tenure as vice president under John Quincy Adams and Andrew Jackson. John Adams, who served as vice president for nearly eight years under George Washington, cast 29 tiebreakers.

Harris, however, has cast more tiebreakers than Adams or Calhoun at the equivalent times in their vice presidencies.

She has primarily broken ties to confirm President Biden’s nominees, although she has also appeared at the Senate dais for other 50-50 splits, like when she voted to begin debate on the American Rescue Plan.

Harris’ role as a tie breaker came into the spotlight again on Sunday, when she broke the tie to advance a long-awaited $740 billion bill that includes provisions to raise corporate taxes, confront climate change, lower prescription drug costs and reduce the federal deficit. Her vote for her was met with applause from the chamber.

The bill’s passage in the Senate first required the support of all 50 Democrats given all Republicans were united in opposition.

The Biden administration and Senate Democratic leadership had been hoping to pass a larger reconciliation package last year, dubbed Build Back Better, but the bill was doomed after Sen. Joe Manchin (DW.Va.) declined to support the package.

Manchin had been negotiating behind closed doors in recent months for the slimmed-down reconciliation package, which passed the Senate on Sunday after gaining the support of Sen. Kyrsten Sinema (D-Ariz.) this week, the final Democratic holdout.

The reconciliation package now heads to the House for consideration.

How often Harris casts a deciding vote during the remainder of Biden’s term will largely depend on the outcome of this year’s Senate midterm elections.

Even Senate Minority Leader Mitch McConnell (R-Ky.) has predicted a close race for the Senate majority.

“I think it’s going to be very tight. We have a 50-50 nation. And I think when this Senate race smoke clears, we’re likely to have a very, very close Senate still, with us up slightly or the Democrats up slightly,” McConnell said Wednesday on Fox New’s “Special Report.”

.

Categories
US

Senate passes Democrats’ sweeping climate, health and tax bill, delivering win for Biden

Washington— The Senate on Sunday passed Democrats’ sweeping economy package designed to combat climate change, address health care costs and raise taxes on large corporations, marking a crucial achievement for President Biden and his party as they look to maintain their hold on Congress in the November midterm elections.

The plan, called the Inflation Reduction Act, cleared the upper chamber by a vote of 51 to 50 along party lines, with Vice President Kamala Harris providing the tie-breaking vote in the evenly divided Senate. Democrats used a fast-track legislative process known as reconciliation to pass the measure in the face of unanimous opposition from Republicans.

“It’s been a long, tough and winding road but at last, at last, we have arrived,” Senate Majority Leader Chuck Schumer said in remarks on the Senate floor as members prepared to vote for final passage. “Today, after more than a year of hard work, the Senate is making history. I am confident the Inflation Reduction Act will endure as one of the defining legislative feats of the 21st century.”

The vote came after a marathon session that lasted through the night and into Sunday afternoon, with Democrats breaking into applause as members cast their final votes. In a process known as a “vote-a-rama,” Republicans offered a slew of amendments that Democrats successfully swatted down over nearly 16 hours of debate.

GOP senators did manage to block a provision that would have capped the price of insulin at $35 a month for those covered under private health care plans. Democrats needed 60 votes to waive reconciliation rules and keep that part of the bill, but it failed 57 to 43, with seven Republicans joining Democrats in support of the measure.

House Democratic leaders announced last week the lower chamber will return from its month-long recess on Friday to take up the legislation, which is expected to pass.

Mr. Biden praised Senate Democrats for passing the plan and acknowledged it required “many compromises.” He urged the House to swiftly approve the bill.

“Today, Senate Democrats sided with American families over special interests, voting to lower the cost of prescription drugs, health insurance, and everyday energy costs and reduce the deficit, while making the wealthiest corporations finally pay their fair share,” the president said in to statement. “I ran for president promising to make government work for working families again, and that is what this bill does — period.”

The package is the culmination of months of negotiations over Mr. Biden’s domestic policy agenda, which at times appeared to be on life support but was revived late last month with the surprise announcement of an agreement between Schumer and Sen. Joe Manchin, a moderate Democrat from West Virginia.

WASHINGTON, DC - AUGUST 6: Senator Joe Manchin (D-WV) chats wit
Sen. Joe Manchin chats with his staffers on Capitol Hill in Washington on Aug. 6, 2022.

Shuran Huang for The Washington Post via Getty Images


While the legislation is much more narrow than the sprawling $3.5 trillion proposal put forth by Mr. Biden last year, the tailored package had the backing of Manchin and Sen. Kyrsten Sinema, a Democrat from Arizona whose support was crucial.

Still, Democrats praise the plan as their answer to addressing rising consumer prices and for its nearly $400 billion investment in fighting climate change, the largest ever. The package allows Medicare to negotiate prescription drug prices, a key Democratic priority that is expected to save hundreds of billions of dollars over the next 10 years. It also extends enhanced health insurance subsidies that were set to expire at the end of the year, and imposes a 15% minimum tax on most corporations that make more than $1 billion each year.

The corporate tax provision emerged as a point of contention as senators neared a final vote on Sunday. Seven Democratic senators — Sinema, Jon Ossoff, Raphael Warnock, Catherine Cortez Masto, Maggie Hassan, Mark Kelly and Jacky Rosen — joined Republicans in backing an amendment put forward by GOP Sen. John Thune of South Dakota exempts some firms with private equity backing from the 15% minimum corporate tax rate. That amendment passed 57 to 43.

To boost clean energy, the measure includes tax credits for buying electric vehicles and manufacturing solar panels and wind turbines. It also provides rebates for consumers who buy energy efficient appliances and provides $4 billion for drought relief.

Schumer lauded the bill as the “boldest climate package” in US history, and called it a “game-changer” and “turning point.”

“It’s been a long time coming,” he said.

One piece of Democrats’ drug-pricing plan — imposing penalties on drug manufacturers that raised prices beyond inflation on private insurers — was removed after it was reviewed by Senate parliamentarian Elizbeth MacDonough. Her approval of the rest of the package, however, cleared the way for the upper chamber to move forward with its consideration of the bill.

The Congressional Budget Office estimates the legislation will cut the deficit by $102 billion over the next 10 years. Republicans, though, argued the plan will have little impact on inflation and instead raise taxes while leading to job losses.

in an interview with “Face the Nation” on Sunday, Sen. Rick Scott, a Republican from Florida, claimed Democrats’ drug pricing plan will harm seniors, while the tax component will increase taxes on Americans.

“Why would you be increasing the cost of government? We’re increasing taxes,” he said.

.

Categories
US

Senate parliamentarian OKs most of Dems’ drug price controls

WASHINGTON (AP) — The Senate parliamentarian narrowed Democrats’ plan for curbing drug prices but left it largely intact Saturday, Democrats said, as party leaders prepared to start moving their sprawling economic bill through the chamber.

Elizabeth MacDonough, the chamber’s rules arbiter, also gave the green light to clean air provisions in the measure, including one limiting electric vehicle tax credits to those assembled in the US, Democrats said.

The nonpartisan official’s rulings came as Democrats planned to begin Senate votes Saturday on their wide-ranging package addressing climate change, energy, health care costs, taxes and even deficit reduction. Party leaders have said they believe they now have the unity they will need to move the legislation through the 50-50 Senate, with Vice President Kamala Harris’ tiebreaking vote.

MacDonough said provisions must be removed that would force drugmakers to pay rebates if their prices rise above inflation for products they sell to private insurers. Pharmaceutical companies would have to pay those penalties, though, if their prices for drugs bought by Medicare rise too high.

Dropping penalties on drugmakers for increasing prices on private insurers was a clear setback for Democrats. The decision reduces incentives on pharmaceutical companies to restrain what they charge, increasing costs for patients.

Erasing that language will cut the $288 billion in 10-year savings that the Democrats’ overall drug curbs were estimated to generate — a reduction of perhaps tens of billions of dollars, analysts have said. But other restrictions on rising pharmaceutical costs survived, including letting Medicare negotiate costs for the drugs it buys, capping seniors’ out-of-pocket expenses and providing free vaccines.

The surviving pharmaceutical provisions left Democrats promoting the drug language as a boon to consumers at a time when voters are infuriated by the worst inflation in four decades.

“This is a major victory for the American people,” Senate Majority Leader Chuck Schumer, DN.Y., said in a statement. “While there was one unfortunate ruling in that the inflation rebate is more limited in scope, the overall program remains intact and we are one step closer to finally taking on Big Pharma and lowering Rx drug prices for millions of Americans.”

Senate Finance Committee Chairman Ron Wyden, D-Ore., said that while he was “disappointed” the penalties for higher drug prices for privately insured consumers were dropped, “the legislation nevertheless puts a substantial check on Big Pharma’s ability to price gouge.”

The parliamentarian’s decision came after a 10-day period that saw Democrats resurrect top components of President Joe Biden’s domestic agenda after they were seemingly dead. In rapid-fire deals with Democrats’ two most unpredictable senators—first conservative Joe Manchin of West Virginiathen Arizona centrist Kyrsten Sinema — Schumer pieced together a broad package that, while a fraction of earlier, larger versions that Manchin derailed, would give the party an achievement against the backdrop of this fall’s congressional elections.

The parliamentarian signed off on a fee on excess emissions of methane, a powerful greenhouse gas contributor, from oil and gas drilling. She also let stand environmental grants to minority communities and other initiatives for reducing carbon emissionssaid Senate Environment and Public Works Committee Chairman Thomas Carper, D-Del.

She approved a provision requiring union-scale wages to be paid if energy efficiency projects are to qualify for tax credits, and another that would limit electric vehicle tax credits to those cars and trucks assembled in the United States.

The overall measure faces unanimous Republican opposition. But assuming Democrats fight off a nonstop “vote-a-rama” of amendments — many designed by Republicans to derail the measure — they should be able to muscle the measure through the Senate.

House passage could come when that chamber returns briefly from recess on Friday.

“What will vote-a-rama be like. It will be like hell,” Sen. Lindsey Graham of South Carolina, the top Republican on the Senate Budget Committee, said Friday of the approaching GOP amendments. He said that in supporting the Democratic bill, Manchin and Sinema “are empowering legislation that will make the average person’s life more difficult” by forcing up energy costs with tax increases and making it harder for companies to hire workers.

The bill offers spending and tax incentives for moving toward cleaner fuels and supporting coal with assistance for reducing carbon emissions. Expiring subsidies that help millions of people afford private insurance premiums would be extended for three years, and there is $4 billion to help Western states combat drought.

There would be a new 15% minimum tax on some corporations that earn over $1 billion annually but pay far less than the current 21% corporate tax. There would also be a 1% tax on companies that buy back their own stock, swapped in after Sinema refused to support higher taxes on private equity firm executives and hedge fund managers. The IRS budget would be pumped up to strengthen its tax collections.

While the bill’s final costs are still being determined, it overall would spend more than $300 billion over 10 years to slow climate change, which analysts say would be the country’s largest investment in that effort, and billions more on health care. It would raise more than $700 billion in taxes and from government drug cost savings, leaving about $300 billion for deficit reduction — a modest bite out of projected 10-year shortfalls of many trillions of dollars.

Democrats are using special procedures that would let them pass the measure without having to reach the 60-vote majority that legislation often needs in the Senate.

It is the parliamentarian’s job to decide whether parts of legislation must be dropped for violating those rules, which include a requirement that provisions be chiefly aimed at affecting the federal budget, not imposing new policy.

___

Associated Press writer Matthew Daly contributed to this report.

.

Categories
US

Kamala Harris labeled hypocrite over Brittney Griner comments

Vice President Kamala Harris was accused of hypocrisy after she decried Brittney Griner’s conviction by Russia on cannabis smuggling charges — despite Harris prosecuting thousands of similar marijuana possession cases in her earlier career as a prosecutor.

Griner, 31, was sentenced on Thursday to nine years in prison after she admitted to bringing vape cartridges containing cannabis oil into the country. The WNBA star said she had been prescribed the oil to help relieve pain related to her chronic injuries and had accidentally packed them in her luggage.

The verdict was met with universal condemnation from US diplomats and government officials, led by President Biden, who called the sentence “unacceptable” and demanded that Russia release both Griner and a second jailed American, Paul Whelan, “immediately.”

Harris released a separate statement on Twitter condemning Griner’s conviction.

VP Kamala Harris has been labeled a hypocrite for condemning Brittney Griner's cannabis conviction in Russia, despite overseeing thousands of marijuana possession cases as a prosecutor.
VP Kamala Harris has been labeled a hypocrite for condemning Brittney Griner’s cannabis conviction in Russia, despite overseeing thousands of marijuana possession cases as a prosecutor.
AP
Griner was found guilty of smuggling cannabis into Russia and was sentenced to nine years in prison.
Griner was found guilty of smuggling cannabis into Russia and was sentenced to nine years in prison.
ZUMAPRESS.com

“With today’s sentencing, Russia continues its wrongful detention of Brittney Griner. She should be released immediately,” Harris wrote. “@POTUS and I, and our entire Administration, are working every day to reunite Brittney, as well as Paul Whelan, with loved ones who miss each of them dearly.”

But Harris’ many critics were quick to point out that while serving as both San Francisco’s district attorney and California’s attorney general, she oversaw thousands of marijuana-related prosecutions and was an outspoken critic of pot legalization, as the Daily Mail first reported.

Tap the right side of the screen below to watch this web story:

Brittney Griner sentenced to 9 years for cannabis possession in Russia

“Brittney Griner got 9 years for drug possession in Russia… which sounds like most of the criminal sentences Kamala Harris got people for the same thing when she was attorney general of California,” author Tim Young tweeted.

Another commenter wrote: “LMAO, didn’t U lock up as—load of people for weed? Then bragged about it, and went on to say you smoked weed in college listening to Tupac and snoop before they cut their first albums?”

A third smoked in the same vein: “You locked up people for possession of marijuana. And you’re only condemning this because the US cannot profit from her incarceration of her in Russia.

The San Jose Mercury News reported in 2019 that during Harris’ tenure as San Francisco’s top prosecutor between 2004-2010, her office handled more than 1,900 marijuana convictions — although it has been pointed out that most of those arrested for low-level possession were spared prison time, and only a few dozen were incarcerated.

Harris was elected the Golden State’s attorney general in 2011 and had a further 1,970 people locked up for marijuana offenses on her watch, according to an investigation by the Washington Free Beacon, a conservative publication.

Harris also vocally opposed California’s marijuana legalization ballot initiative, which ultimately passed in 2016.

She only threw her support behind legalization around 2018, even endorsing a bill which would have removed cannabis from the Controlled Substances Act, reported Forbes. She also wrote a book in which she argued for the decriminalization of cannabis.

By the time Harris radically changed her stance on marijuana, there was already talk of her running for president.

Harris famously sparred with Hawaii Rep. Tulsi Gabbard during a Democratic presidential debate in 2019 after Gabbard brought up her record of throwing people in prison for marijuana possession.

“She put over 1,500 people in jail for marijuana violations and then laughed about it when she was asked if she ever smoked marijuana,” Gabbard said, referring to Harris’ interview with the radio show “The Breakfast Club.”

In that sitdown, the White House contender — and former prosecutor — admitted with a laugh that she had smoked marijuana in college, saying: “I have. And I inhaled—I did inhale. It was a long time ago. But, yes.”

.

Categories
US

Trump beats Biden, Harris in hypothetical 2024 match-up: poll

Former President Trump leads President Biden and Vice President Harris in hypothetical 2024 presidential match-ups, according to a new Harvard CAPS-Harris Poll survey released exclusively to The Hill on Monday.

The poll found that if the 2024 election were held today, 45 percent of respondents would vote for Trump in a race against Biden, who attracted the support of 41 percent of respondents, while 14 percent were unsure or didn’t know.

In a hypothetical Trump-Harris match-up, Trump’s lead expands to 7 percentage points. Forty-seven percent said they would support Trump, compared to 40 percent for Harris and 13 percent who were unsure or didn’t know.

Mark Penn, the co-director of the Harvard CAPS-Harris Poll survey, noted how Biden would be a weaker candidate in a race against Trump today than he performed in 2020.

“Biden is a very weak Democratic nominee and would lose even the popular vote in a rematch today,” Penn said. “Trump is far from 50 percent support, and there is a high undecided vote despite everyone knowing the candidates, because the public wants new over more of the same.”

The poll comes as Biden’s approval rating remains at roughly the lowest point in his presidency. The poll found his approval rating of him clocked in at 38 percent, which was unchanged from when the pollsters asked the question a month ago.

Biden and White House officials have repeatedly said the president intends to run in 2024 if his health allows.

Trump, meanwhile, has tipped closer to another White House bid, but some Republican lawmakers have publicly suggested Trump should wait to announce until after the midterm elections to avoid shifting the focus away from inflation when voters head to the ballot box in November.

The two presidents’ and Harris’s favorability ratings, however, all remain underwater.

Thirty-seven percent of those surveyed said they had a favorable view of Biden, compared to 44 percent for Trump. Just thirty-six percent of voters said they had a favorable view of Harris.

A majority of respondents indicated they did not want Trump nor Biden to run in 2024.

Nearly 7 in 10 respondents — 69 percent — said Biden should not run for a second term, while 59 percent of respondents said Trump shouldn’t run.

The poll was conducted online on July 27-28 among 1,885 registered voters in a collaboration between the Center for American Political Studies at Harvard University and the Harris Poll.

The survey is weighted to reflect known demographics, and as a representative online sample, it does not report a probability confidence interval.

.